Revista Colombiana de Cancerologia

Scope & Guideline

Exploring New Frontiers in Oncology

Introduction

Welcome to the Revista Colombiana de Cancerologia information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Revista Colombiana de Cancerologia, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN0123-9015
PublisherINST NACIONAL CANCEROLOGIA
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationREV COLOMB CANCEROL / Rev. Colomb. Cancerol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCALLE 1 NO 9-85, APDO AEREO 17158, BOGOTA 00000, COLOMBIA

Aims and Scopes

The 'Revista Colombiana de Cancerología' is dedicated to advancing knowledge and practice in oncology through the dissemination of high-quality research. The journal focuses on various aspects of cancer care, including clinical, epidemiological, and therapeutic studies, with a particular emphasis on the Colombian context. The following areas represent the journal's core aims and scopes:
  1. Clinical Oncology:
    The journal publishes research on the diagnosis, treatment, and management of various cancers, highlighting innovative clinical practices and outcomes.
  2. Epidemiology and Public Health:
    Research focusing on cancer incidence, risk factors, and population health strategies in Colombia and Latin America is a significant component of the journal's content.
  3. Multidisciplinary Collaboration:
    The journal emphasizes the importance of teamwork among various healthcare professionals in cancer care, including oncologists, surgeons, radiologists, and nurses.
  4. Innovative Treatment Modalities:
    Studies on new therapies, including targeted therapies, immunotherapy, and advances in radiotherapy, are regularly featured, reflecting the journal's commitment to cutting-edge cancer treatment.
  5. Palliative Care and Quality of Life:
    Research addressing the psychosocial aspects of cancer care, including palliative care strategies and quality of life for patients, is an essential focus area.
  6. Case Reports and Reviews:
    The journal includes case reports and literature reviews that provide insights into rare and complex cancer cases, contributing to the understanding of diverse clinical scenarios.
The 'Revista Colombiana de Cancerología' has shown a dynamic evolution in its research themes, reflecting emerging trends and the changing landscape of cancer care. These emerging scopes are vital for addressing contemporary challenges in oncology. Below are the key trending themes:
  1. Multidisciplinary Cancer Care Models:
    Recent publications emphasize the need for integrated approaches in cancer treatment, showcasing models that incorporate various specialties to improve patient outcomes.
  2. Telemedicine and Remote Patient Management:
    The rise of telemedicine, especially post-COVID-19, has led to increased research on remote care strategies, demonstrating a shift towards more accessible cancer care.
  3. Patient-Centered Care and Quality of Life:
    There is a growing focus on studies that assess patient-reported outcomes and quality of life, reflecting a broader understanding of the importance of holistic cancer care.
  4. Innovations in Radiotherapy Techniques:
    Research on novel radiotherapy methods, including intraoperative radiotherapy and advanced fractionation schemes, indicates a trend towards improving treatment precision and minimizing side effects.
  5. Oncology Nursing and Advanced Practice:
    The role of nursing in oncology, particularly advanced practice nursing, is gaining recognition, leading to an increase in related studies highlighting their impact on patient care.
  6. Public Health Initiatives and Cancer Prevention:
    There is a notable trend towards exploring public health strategies aimed at cancer prevention and early detection, addressing the need for comprehensive cancer control programs.

Declining or Waning

While the 'Revista Colombiana de Cancerología' has a robust and evolving focus, certain themes appear to be declining in prominence over recent years. This shift may reflect changes in research priorities, funding, or advancements in the field. The following points outline these waning scopes:
  1. Traditional Chemotherapy:
    As new treatment modalities such as immunotherapy and targeted therapies gain traction, traditional chemotherapy regimens are being studied less frequently, suggesting a shift towards more innovative approaches.
  2. Basic Science Research:
    The focus on basic science and molecular biology related to cancer has diminished, possibly due to the journal's prioritization of clinical and applied research that directly impacts patient care.
  3. Regional Cancer Disparities:
    While previously a point of interest, the specific examination of regional disparities in cancer care and outcomes has become less frequent, potentially overshadowed by broader public health discussions.
  4. Longitudinal Studies:
    There has been a noticeable decrease in the publication of long-term follow-up studies, which are critical for understanding the long-term effects and outcomes of cancer treatments.
  5. Epidemiological Studies with Limited Scope:
    Epidemiological research that lacks comprehensive data or focuses narrowly on specific populations has seen a decline, possibly due to the increasing demand for data-rich studies.

Similar Journals

Cancer Medicine

Unveiling the future of cancer therapies and treatments.
Publisher: WILEYISSN: 2045-7634Frequency: 12 issues/year

Cancer Medicine is a leading open access journal published by WILEY, focusing on innovative research and advancements in the fields of Cancer Research, Oncology, and Radiology, with an impressive impact evidenced by its 2023 Q2 ranking in Cancer Research and Q1 rankings in both Oncology and Radiology, Nuclear Medicine and Imaging. With an ISSN of 2045-7634, this journal has been committed to disseminating pivotal findings since its inception in 2012, serving as a vital platform for researchers, practitioners, and students alike. The journal proudly embodies the spirit of open access, ensuring that groundbreaking cancer research is accessible to a global audience. Located in the United Kingdom, it spans a wide array of topics, promising comprehensive insights into cancer therapies, molecular mechanisms, and imaging techniques, thereby significantly contributing to the enhancement of cancer care and treatment outcomes. Researchers interested in exploring the latest advancements in cancer medicine will find this journal an indispensable resource.

World Journal of Clinical Oncology

Fostering Collaboration in the Fight Against Cancer
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 2218-4333Frequency: 12 issues/year

World Journal of Clinical Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a vital resource in the realm of oncology, providing a dedicated platform for the dissemination of cutting-edge research and clinical advancements. With an ISSN of 2218-4333, this journal facilitates a comprehensive exploration of modern oncology challenges and breakthroughs, targeting researchers, healthcare professionals, and students alike. Although it operates under the traditional subscription model, the impactful nature of its content is reflected in its notable ranking of 60 out of 334 in the category of Medicine _ Oncology, placing it in the 82nd percentile among peer publications. Covering significant topics in clinical oncology from 2014 to 2018, the journal has been instrumental in addressing evolving oncology practices and patient care innovations. By publishing high-quality studies, it remains an essential tool for advancing knowledge and fostering collaboration within the global oncology community.

Cancers

Transforming cancer knowledge into impactful solutions.
Publisher: MDPIISSN: Frequency: 24 issues/year

Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.

CLINICAL ONCOLOGY

Driving Innovation in Oncology and Imaging for Better Health
Publisher: ELSEVIER SCIENCE LONDONISSN: 0936-6555Frequency: 6 issues/year

Clinical Oncology is a prestigious peer-reviewed journal published by Elsevier Science London, focusing on the dynamic fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an impressive impact factor reflecting its high-quality research contributions, the journal is ranked in the second quartile for oncology and the first quartile for radiology, underscoring its importance in advancing clinical knowledge and practice. Established in 1975, Clinical Oncology offers researchers, healthcare professionals, and students robust access to cutting-edge studies, reviews, and clinical trials that drive innovation and improve patient care. Based in the United Kingdom, the journal plays a vital role in disseminating significant findings, fostering collaboration, and enhancing education in the biosciences, particularly for those committed to addressing the challenges in cancer treatment and diagnostics. Given its rigorous selection criteria and broad readership, Clinical Oncology remains an essential resource for anyone dedicated to the fields of oncology and radiology.

Current Oncology

Leading the Charge in Oncology Innovation
Publisher: MDPIISSN: 1198-0052Frequency: 12 issues/year

Current Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.

Case Reports in Oncological Medicine

Empowering healthcare professionals with valuable case reports.
Publisher: HINDAWI LTDISSN: 2090-6706Frequency: 1 issue/year

Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.

South Asian Journal of Cancer

Championing open access to vital cancer research.
Publisher: GEORG THIEME VERLAG KGISSN: 2278-330XFrequency: 4 issues/year

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

Asia-Pacific Journal of Clinical Oncology

Connecting oncology professionals for a healthier tomorrow.
Publisher: WILEYISSN: 1743-7555Frequency: 6 issues/year

Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

International Journal of Clinical Oncology

Pioneering Discoveries in Clinical Oncology
Publisher: SPRINGER JAPAN KKISSN: 1341-9625Frequency: 6 issues/year

International Journal of Clinical Oncology, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing research and clinical practices in the fields of oncology, hematology, and surgery. With its impact factor reflecting its significance and reach in the academic community, this journal serves as a solid platform for researchers, professionals, and students to share and disseminate groundbreaking discoveries and methodologies. Notably, it has secured prestigious rankings in the Q1 category in Medicine (miscellaneous) and Surgery, and Q2 in Hematology and Oncology, illustrating its prominent position in the medical literature. The journal's comprehensive scope addresses pivotal clinical issues from 1996 through 2024, further solidifying its relevance in the ever-evolving landscape of cancer research. Despite not offering open access, the depth and quality of research articles ensure that vital information remains accessible to those committed to improving clinical outcomes in oncology. With a focus on innovative treatments and patient care, the International Journal of Clinical Oncology embodies a commitment to fostering excellence in medical research.

Tumori Journal

Advancing Cancer Research, One Insight at a Time.
Publisher: SAGE PUBLICATIONS LTDISSN: 0300-8916Frequency: 6 issues/year

Tumori Journal is a distinguished publication in the field of oncology, dedicated to advancing the understanding and treatment of cancer since its inception in 1946. Published by SAGE Publications Ltd, this Italian journal serves as a pivotal platform for researchers, clinicians, and academicians to disseminate cutting-edge findings in cancer research and related areas of medicine. With an impressive record of contributions spanning multiple decades, Tumori Journal aims to foster collaboration and dialogue among professionals in the oncology community. Although classified in the Q4 category for Cancer Research and the Q3 category for both Medicine (miscellaneous) and Oncology as of 2023, the journal continues to draw interest with its rigorous peer-review process and commitment to quality. Researchers are encouraged to explore innovative methodologies and share impactful clinical insights through the journal, which also ranks within the top tiers of Scopus metrics for oncology and cancer research domains. With a growing emphasis on accessible research, Tumori Journal remains an essential resource in the continuous fight against cancer.